Description

Methylprednisolone Tablet

Methylprednisolone Tablets USP / BP / IP (4 mg / 8 mg / 16 mg)

Healthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is a leading Indian manufacturer, CDMO services provider, and wholesale exporter of advanced immunology, rheumatology, and systemic anti-inflammatory therapeutics. We manufacture ultra-high-purity, kinetically stable Methylprednisolone Tablets inside our WHO–GMP certified, high-precision solid dosage manufacturing installations. This highly potent “Synthetic Glucocorticoid Corticosteroid” serves as a high-volume strategic export to rheumatology units, pulmonology networks, public hospital infrastructures, national procurement tenders, and international B2B wholesale marketplaces across Europe, the CIS region, Africa, LATAM, and Southeast Asia.

Product Overview

This formulation operates as a “Nuclear Gene Transcription Modifier.” It ensures patient safety and cellular stabilization during severe systemic immune overactivation by suppressing the synthesis of pro-inflammatory cytokines and arresting leucocyte migration.

• Mechanism 1 (Cytoplasmic Receptor Activation): Methylprednisolone physically diffuses across target cell membranes and chemically binds with high affinity to glucocorticoid receptors (GR) in the cytoplasm.

• Mechanism 2 (Nuclear Translocation & Gene Suppression): The structural drug-receptor complex physically translocates into the cell nucleus. Here, it chemically binds to specific DNA sequences (Glucocorticoid Response Elements), repressing the transcription of nuclear factor kappa B ($NF\text{-}κB$) and activator protein-1 ($AP\text{-}1$). This completely halts the production of pro-inflammatory cytokines, interleukins ($IL\text{-}1, IL\text{-}2, IL\text{-}6$), and $TNF\text{-}alpha$.

• Mechanism 3 (Cellular Adhesion Inhibition): It chemically down-regulates endothelial cell adhesion molecules and suppresses the production of arachidonic acid metabolites via phospholipase $A_{2}$ inhibition. This physically prevents neutrophils, macrophages, and T-lymphocytes from migrating into inflamed tissues.

Product Composition & Available Strengths

We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.

Technical & Logistics Specifications

• HS Code: 3004.32.00 (Medicaments containing corticosteroid hormones, their derivatives or structural analogues)

• CAS Number: 83-43-2 (Methylprednisolone)

• Dosage Form: Oral Solid Tablet (Engineered for immediate release and micro-gram content uniformity)

• Packaging Configurations: 10 Tablets per Blister Strip packed in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC strips, or specialized 6-Day Compliance Taper Dose Blister Packs (21 Tablets of 4mg arranged sequentially). Our premium tropicalized packaging configurations physically seal out environmental humidity and UV rays, guaranteeing a full 36-month shelf life in hot, humid Zone IVb export environments.

Manufacturing Authority & Compliance

• Hormonal Isolation Manufacturing Protocols: Methylprednisolone is a highly potent synthetic corticosteroid that demands strict containment to prevent crossover contamination. Our processing blocks execute synthesis and tableting inside Dedicated, Air-Pressure Segregated Steroidal Suites running automated, independent HEPA-filtered HVAC infrastructure, completely satisfying rigid international B2B regulatory audits.

• Micro-Dose Blending Precision: Because low-dose tablets (4 mg / 8 mg) require extreme accuracy to avoid precipitating adrenal insufficiency or Cushingoid spikes, we deploy Automated Multi-Stage Geometric Solid Blenders with Online Weight Verification Checkers, physically ensuring absolute chemical uniformity.

• Validated Release Kinetics: Every production batch physically undergoes Automated Dissolution Profiling, chemically validating that our generic solid doses match the exact kinetic curves and bioequivalence benchmarks of global innovator references (such as Medrol).

Primary Indications

• Rheumatology & Autoimmune Care: Acute management and maintenance of Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), acute gouty arthritis, and dermatomyositis.

• Pulmonology: Stabilization of severe acute Asthma Exacerbations, chronic obstructive pulmonary disease (COPD) flares, and symptomatic sarcoidosis.

• Allergy & Immunology: Suppression of severe, intractable allergic conditions, including Serum Sickness, Severe Allergic Rhinitis, and Drug Hypersensitivity Reactions.

• Dermatology: Treatment of Pemphigus, severe Erythema Multiforme (Stevens-Johnson syndrome), and exfoliative dermatitis.

Usage Instructions

• The Food Catalyst & Circadian Alignment: Doses must be taken physically in the morning (ideally before 9:00 AM) with or immediately after a meal to mimic the body’s natural diurnal cortisol release curve and physically minimize gastrointestinal mucosal irritation.

• The Absolute Taper Mandate: Advise clinical and pharmacy networks that patients on long-term therapy must NEVER halt this medication abruptly. Chronic administration chemically suppresses the Hypothalamic-Pituitary-Adrenal (HPA) axis; sudden withdrawal can physically trigger a life-threatening Acute Adrenal Crisis. Doses must be tapered down progressively under direct medical supervision.

• Clinical Monitoring Requirements: For patients on prolonged maintenance protocols, regular physical tracking of blood pressure, blood glucose levels (due to steroid-induced hyperglycemia risks), bone mineral density, and ophthalmic pressure is highly recommended.

Safety Warning: POTENT CORTICOSTEROID SYSTEMIC IMMUNOSUPPRESSANT. For Professional Medical Supervision Only. Adrenal Suppressive Hazard: Never discontinue therapy abruptly; taper doses gradually over weeks to prevent severe adrenal crisis. Infection Masking Note: Glucocorticoids chemically suppress immune responses and may physically mask clinical signs of systemic fungal, bacterial, or viral infections. Contraindications: Absolute contraindication in patients presenting with systemic fungal infections, active untreated tuberculosis, ocular herpes simplex, or known hypersensitivity to methylprednisolone matrices.

Global CDMO Services & Wholesale Supply Chain

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export pipelines for the entire Methylprednisolone dosage spectrum. Whether you are executing a high-volume procurement contract for a National Health Ministry Tender across the CIS region, supplying a regional hospital purchasing cooperative in Africa, or maintaining an active inventory listing on an international digital B2B Pharmaceutical Marketplace across Southeast Asia or LATAM, we deliver all required documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for seamless global registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Corporate Email: info@healthyinc.co.in